StonvexLoading…
StonvexStonvexStonvexCore line items from EYE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q2 2026 2026-04-04 | Annual 2026 2026-01-03 | Q3 2025 2025-09-27 | Q2 2025 2025-06-28 |
|---|---|---|---|---|
Revenue | $543.88M | $1.99B | $1.48B | $996.75M |
Operating Income | $45.24M | $58.83M | $52.19M | $42.59M |
Net Income | $31.18M | $29.60M | $26.28M | $8.72M |
EPS (Diluted) | $0.38 | $0.37 | $0.33 | $0.29 |
Total Assets | $2.02B | $1.98B | $1.96B | $1.97B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $67.90M | $38.71M | $56.03M | $48.47M |
Free Cash Flow OCF − CapEx | $44.14M | $73.45M | $84.69M | $54.42M |
Shares Outstanding | 80.11M | 79.42M | 79.26M | 79.17M |